title: Regulation of ERK-mediated signal transduction by p38 MAP kinase in human monocytic THP-1 cells.
abstract: SB 203580 has been widely used to specifically shut down the p38 MAP kinase-dependent pathway, although it is capable of inducing c-Raf kinase activity in cells. The present study demonstrates that SB 203580 activates members of the ERK cascade, c-Raf, MEK, and ERK, in human monocytic THP-1 cells. The activation of these kinases was sustained for at least 24 h after SB 203580 treatment and was also observed in U937 cells, suggesting that c-Raf efficiently transduces the signal even in the presence of the inhibitor in these cells. However, the expression of ERK cascade-dependent genes, such as c-fos and IL-1beta, was extremely limited. Analysis of the cellular distribution of ERK in SB 203580-treated cells indicated that nuclear translocation of phosphorylated ERK was impaired. Also, nuclear translocation of ERK induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) was inhibited by SB 239063, which does not associate with c-Raf and is highly selective for p38 MAP kinase. In addition, the forced expression of the dominant negative mutant of p38 MAP kinase suppressed serum responsive element-dependent transactivation induced by TPA. These results suggest that the steady-state level of p38 MAP kinase activity modulates ERK signaling.
authors.affiliation: Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-8555. numazawa@pharm.showa-u.ac.jp
authors.forename: Satoshi
authors.initials: S
authors.lastname: Numazawa
authors.forename: Masahiko
authors.initials: M
authors.lastname: Watabe
authors.forename: Satoshi
authors.initials: S
authors.lastname: Nishimura
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kurosawa
authors.forename: Makoto
authors.initials: M
authors.lastname: Izuno
authors.forename: Takemi
authors.initials: T
authors.lastname: Yoshida
mesh_terms: D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D019556:COS Cells; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D015870:Gene Expression; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008156:Luciferases / Q000378:metabolism; D020935:MAP Kinase Signaling System / Q000502:physiology*; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism*; D009000:Monocytes / Q000201:enzymology*; D019908:Proto-Oncogene Proteins c-raf / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D027602:Serum Response Element / Q000502:physiology; D015533:Transcriptional Activation; D014162:Transfection; D048051:p38 Mitogen-Activated Protein Kinases
chemical_list: D007093:Imidazoles; D011725:Pyridines; D008156:Luciferases; D019908:Proto-Oncogene Proteins c-raf; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; C093642:SB 203580